TELA Bio, Inc. Common Stock (TELA) is a publicly traded Healthcare sector company. As of July 21, 2026, TELA trades at $0.73 with a market cap of $32.72M and a P/E ratio of -0.92. TELA moved +0.00% today. Year to date, TELA is -35.71%; over the trailing twelve months it is -66.19%. Its 52-week range spans $0.50 to $3.20. Analyst consensus is buy with an average price target of $1.67. Rallies surfaces TELA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TELA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.73 |
| Market Cap | $32.72M |
| P/E Ratio | -0.92 |
| EPS | $-0.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.20 |
| 52-Week Low | $0.50 |
| Volume | 11.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $80.81M |
| Net Income | $-39.84M |
| Gross Margin | 67.25% |
3 analysts cover TELA: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.67.